Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Evonik Industries AG's Debt-to-EBITDA or its related term are showing as below:
XSWX:EVK'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.59 Med: 2.05 Max: 2.46
Current: 2.21
During the past 13 years, the highest Debt-to-EBITDA Ratio of Evonik Industries AG was 2.46. The lowest was 1.59. And the median was 2.05.
XSWX:EVK's Debt-to-EBITDA is ranked worse than 50.65% of 1234
companies
in the Chemicals industry
Industry Median: 2.16
vs XSWX:EVK: 2.21
Evonik Industries AG (XSWX:EVK) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Evonik Industries AG Debt-to-EBITDA Related Terms
Evonik Industries AG Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Evonik Industries AG's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:EVK vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Evonik Industries AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Evonik Industries AG (XSWX:EVK) has a Debt-to-EBITDA of 0.00 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Evonik Industries AG. Over the past decade, Evonik Industries AG's Debt-to-EBITDA has ranged from 1.59 to 2.46. According to the industry distribution chart, Evonik Industries AG ranks #625 out of 1234 companies in the Chemicals industry, placing it in the top 50.6%.
Is Evonik Industries AG's Debt-to-EBITDA too high?
Evonik Industries AG's current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 1.59 to a high of 2.46. Based on the distribution chart, Evonik Industries AG ranks #625 out of 1234 companies in the Chemicals industry, which is below the industry midpoint. Overall, Evonik Industries AG has a GF Score™ of 16/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Evonik Industries AG ranks #625 out of 1234 companies for Debt-to-EBITDA. This places Evonik Industries AG in the lower half of its industry. The industry median Debt-to-EBITDA is 2.16. Historically, Evonik Industries AG's own Debt-to-EBITDA has ranged from 1.59 to 2.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,234 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Evonik Industries AG. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evonik Industries AG's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (XSWX:EVK) is currently considered Fairly Valued. The stock's GF Value™ is CHF14.45, compared to a current price of CHF15.08 — trading 4.4% above its estimated fair value. The current Debt-to-EBITDA is 0.00. Evonik Industries AG's overall GF Score™ is 16/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Debt-to-EBITDA is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued.
The current stock price of CHF15.08 is trading 4.4% above its estimated GF Value™ of CHF14.45.
GuruFocus considers Evonik Industries AG to be Fairly Valued.
Key valuation signals for XSWX:EVK:
Debt-to-EBITDA: 0.00
GF Value™: CHF14.45 vs. price of CHF15.08 (4.4% above fair value)
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
16GF Score
Get the complete analysis for XSWX:EVK
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
